CAPS1 antibody

Eine Lieferung in diese Region ist nicht möglich.

SKU:: GTX85037
Zusätzliche Namen:: calcium dependent secretion activator , CADPS1 , CAPS , CAPS1 , UNC-31
Anwendung:: ELISA, WB, IHC-P
Konzentration:: 1 mg/ml
Physischer Zustand:: Liquid
Spezies-Reaktivität:: Human
Aufreinigung:: Affinity Purified
Lagerbedingungen:: -20[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted., 2-8[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted., -20[o]C/-70[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted.
Hersteller:: Genetex
Host:: Rabbit
Reaktivitäten:: Human, Mouse, Rat
Buffer:: PBS, 0.02% Sodium azide.
Immunogen:: CAPS1 antibody was raised against a 20 amino acid synthetic peptide near the carboxy terminus of the human CAPS1.The immunogen is located within the last 50 amino acids of CAPS1.
Uniprot:: Q9ULU8
Synonyme:: Ca++-dependent secretion activator;Ca2+ dependent secretion activator;Ca2+-dependent activator protein for secretion;Ca2+-regulated cytoskeletal protein;CADPS1;calcium-dependent activator protein for secretion 1;calcium-dependent secretion activator 1;CAPS;CAPS-1;CAPS1;UNC-31
Weitere Details:: CAPS1 and its related protein CAPS2 encode novel neural/endocrine-specific cytosolic and peripheral membrane proteins. Both are essential components of the synaptic vesicle priming machinery and are required for the Ca2+-regulated exocytosis of secretory vesicles; CAPS-deficienct neurons contain no or very few fusion competent synaptic vesicles, causing a selective impairment of fast phasic transmitter release. CAPS1 acts at a stage in exocytosis that follows ATP-dependent priming, which involves the essential synthesis of phosphatidylinositol 4,5-bisphosphate and is thought to be a specific regulator of large dense-core vesicle fusion. Numerous isoforms of CAPS1 are known to exist; the lower molecular weight bands seen in the immunoblot image are likely to be these isoforms. This CAPS1 antibody is predicted to be specific to CAPS1 and not recognize CAPS2.

Versandbedingungen:: Blue Ice